General Information of the Compound
Compound ID
CP0955790
Compound Name
(4S,7S,13S,16S,19S,22S,25S,28S,31S)-4-((4S,7S,10S,13S,16S,19S,22S,25S,28S,34S,37S,40S,43S,46S,49S,52S,55S,58S)-43-((1H-indol-3-yl)methyl)-62-amino-16-(3-amino-3-oxopropyl)-49,55-bis(4-aminobutyl)-19,25-di-sec-butyl-58-carbamoyl-10,52-bis(3-guanidinopropyl)-40-((R)-1-hydroxyethyl)-28,37,46-tris(hydroxymethyl)-7-isopropyl-2,13,22-trimethyl-34-(2-(methylthio)ethyl)-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56-octadecaoxo-6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57-octadecaazadohexacontan-4-ylcarbamoyl)-31-acetamido-19-(4-aminobutyl)-22-sec-butyl-28-(2-carboxyethyl)-7-(3-guanidinopropyl)-13-(hydroxymethyl)-16-isobutyl-25-isopropyl-6,9,12,15,18,21,24,27,30-nonaoxo-5,8,11,14,17,20,23,26,29-nonaazatetratriacontane-1,34-dioic acid
    Show/Hide
Formula
C146H253N45O42S
Molecular Weight
3342.97
Canonical SMILES
CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(C)=O)C(C)C)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O)[C@@H](C)O
    Show/Hide
InChI
InChI=1S/C146H253N45O42S/c1-20-76(12)113(140(230)166-80(16)119(209)188-114(77(13)21-2)142(232)185-102(69-193)121(211)164-67-107(200)169-97(53-61-234-19)130(220)183-104(71-195)137(227)191-116(81(17)196)143(233)181-100(64-83-65-162-85-37-24-23-36-84(83)85)134(224)184-103(70-194)136(226)174-89(40-27-31-56-149)125(215)173-92(44-35-60-161-146(157)158)126(216)172-88(39-26-30-55-148)124(214)170-86(117(152)207)38-25-29-54-147)189-132(222)94(45-49-105(151)198)171-118(208)79(15)165-122(212)91(43-34-59-160-145(155)156)177-138(228)111(74(8)9)187-135(225)99(63-73(6)7)180-129(219)95(47-51-109(203)204)175-123(213)87(42-33-58-159-144(153)154)168-106(199)66-163-120(210)101(68-192)182-133(223)98(62-72(4)5)179-127(217)90(41-28-32-57-150)178-141(231)115(78(14)22-3)190-139(229)112(75(10)11)186-131(221)96(48-52-110(205)206)176-128(218)93(167-82(18)197)46-50-108(201)202/h23-24,36-37,65,72-81,86-104,111-116,162,192-196H,20-22,25-35,38-64,66-71,147-150H2,1-19H3,(H2,151,198)(H2,152,207)(H,163,210)(H,164,211)(H,165,212)(H,166,230)(H,167,197)(H,168,199)(H,169,200)(H,170,214)(H,171,208)(H,172,216)(H,173,215)(H,174,226)(H,175,213)(H,176,218)(H,177,228)(H,178,231)(H,179,217)(H,180,219)(H,181,233)(H,182,223)(H,183,220)(H,184,224)(H,185,232)(H,186,221)(H,187,225)(H,188,209)(H,189,222)(H,190,229)(H,191,227)(H,201,202)(H,203,204)(H,205,206)(H4,153,154,159)(H4,155,156,160)(H4,157,158,161)/t76-,77-,78-,79-,80-,81+,86-,87-,88-,89-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,111-,112-,113-,114-,115-,116-/m0/s1
    Show/Hide
InChIKey
QAPGXEBMPBJRHL-YXVSZBTKSA-N
Physicochemical Property
logP
-14.61129
Rotatable Bonds
120
Heavy Atom Count
234
Polar Areas
1448.7
Hydrogen Bond Donor Count
53
Hydrogen Bond Acceptor Count
47
Complexity
234

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4765167
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05999, Relaxin receptor 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000708 OVCAR-5 Homo sapiens (Human)  1
1
EC50 = 897 nM
   TI
   LI
   LO
   TS